kratom fda ban

The FDA’s Proposed Kratom Ban is a Mistake

Trust in the U.S. Food and Drug Administration (FDA) declined after its approval of the controversial Alzheimer’s drug aducanumab. Three experts resigned amid allegations that the FDA had caved to industry pressure. Some argue that its credibility has reached a new low. These events should have prompted the FDA to pause, reflect, and work to repair its reputation. Instead, the

cannabis M&A closing conditions

Cannabis M&A: Common Closing Conditions

Most business purchase transactions we see in the cannabis space are structured to have a concept of “closing”, which I’ve described before here. Essentially, this means that the parties sign, there is some gap of time for them to take care of certain things, and then the business is sold. Today, I want to examine

california cannabis conversion litigation

California Cannabis Claims: Conversion

Last year, we wrote a mini-series on the five most common causes of action we were seeing in the evolving world of cannabis litigation. Given that we’re seeing some other trends (I last wrote about defamation back in January), we’re going to continue on with another often-included cause of action: conversion. Introduction Conversion is defined

FREE Webinar - Cannabis Litigation: What You Need to Know

FREE Webinar – Cannabis Litigation: What You Need to Know

Watch HERE! Cannabis disputes are unique. They are typically more complex than disputes involving other industries and they are often “bet the business” affairs. Over the years, we have developed and prosecuted successful litigation strategies for many of our clients across the country and around the world. Harris Bricken litigators regularly advise cannabis and hemp

cannabis marijuana bankruptcy

Cannabis Bankruptcy 101

In a prior post, we discussed some of the emerging trends for cannabis-related companies that seek bankruptcy protection (click here to view the prior post). But, in the first instance, the question is whether a cannabis-related company can file for bankruptcy relief? This post will examine the first decision from Arizona in the case of

ketamine corporate practice of medicine

Ketamine Ventures: The Strictest Corporate Practice of Medicine States

Certain states are better than others when it comes to lucrative ketamine ventures. Whether you’re a physician looking to open a clinic in the space, or if you’re a third party lay person or entity looking to fund or manage such a practice, you need to be on the look-out for states with strict corporate

costa rica cannabis marijuana

Costa Rica to Debate Hemp and Medical Cannabis Bill

Costa Rican legislators are set to reinitiate debate over a bill (Expediente N.° 21.388) to legalize hemp and medical cannabis. The bill was cleared by the Legislative Assembly’s Environment Commission last November, but its presentation to the assembly’s plenum has been delayed. The bill’s author is independent legislator Zoila Rosa Volio, an agronomist and lawyer,

fda cbd ndi hemp

The FDA Continues to Show It Is Not Interested in Regulating Hemp-Derived Products

Last week, the Food and Drug Administration (the “FDA”) maintained its strict and narrow position on the legality of cannabidiol (“CBD”) by rejecting two new dietary ingredient (“NDI”) notifications submitted by Charlotte’s Web and Irwin Naturals. Both companies sought agency clearance to market their full-spectrum hemp extract as “dietary supplements.” In its letters to these